ArticleCancers2019

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.

Federico Nichetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.